Residual Potential of Dexamethasone and its Effect on Goat Milk
Muhammad Atif Khan1,
Shamsuddin Bughio1*, Rehana Buriro1, Muhammad Bilawal
Arain1, Saeed Ahmed Soomro2, Gulfam Ali Mughal3
and Zainab Lanjar1
1Department of Veterinary
Pharmacology, Sindh Agriculture University, Tandojam 70064, Pakistan
2Department of Veterinary
Physiology and Biochemistry Sindh Agriculture University, Tandojam 70064,
Pakistan
3Department of Animal
Nutrition, Sindh Agriculture University, Tandojam 70064, Pakistan
*For correspondence:
shams_bughio@yahoo.com
Received 07 October 2021; Accepted 20 November 2021;
Published 30 January 2022
Abstract
The
aim of this study was to analyse the effect of intramuscular administration of
dexamethasone (DXM) on clinical, residual and milk composition parameters in
goat. For this, 0.5 mg/kg BW dose of DXM was administered once daily for 3
consecutive days. Milk samples were collected before and after
drug administration at
2, 8, 16, 32, 48, 72, 96, 120, 144, 168 h. Pulse rate and respiratory rate were
increased (P ˂ 0.05) in at 2, 8,
16, 32, 48 and 72 and 96 h While, the rectal temperature was increased (P < 0.05) only at 02 h post drug administration. The highest
residual level of DXM was noticed at 32 h (2.70 ng/mL) and lowest at 168 h
(0.25 ng/mL) in milk. Milk Fat increased (P
˂ 0.01) at 32, 48 and 72 h and (P
< 0.05) at 2, 8, 16, 96,120 h and then gradually returned to pre-treatment
value at 144 h. The mean milk protein level was increased (P ˂ 0.01) at 8, 16, 32, 48, 72 and 120 h and (P < 0.05) at 2 and 96 h. Milk Solid
Not Fat level was increased (P < 0.05)
at 16, 32, 48, 72 and 96 h, however, at 120 h this increase was (P < 0.01). Milk yield decreased (P ˃ 0.05) from
2 – 16 h as compared to control then,
decreased (P < 0.05) at 32, 48,
72, 96, 120, 144 h post DXM administration. It has been concluded that the
therapeutic dose of DXM 0.5
mg/kg BW once daily for 3 consecutive days produced significant effects on
clinical, residual level and milk composition parameters in goat. © 2022
Friends Science Publishers
Keyword: Dexamethasone; Goat; Milk; Potential; Residues
Introduction
Milk secretion from mammary glands is the main characteristic of all female mammals.
The natural milk is important for young ones because it contains complete
nutrients like carbohydrates, proteins, minerals and vitamins in an appropriate
amount with little bit variation among various species of animals (Roadhouse and Henderson 1950).
Within a particular specie, genetic factors, environmental conditions such as
climate and stage of lactation may also affect the composition of milk. Usage of
various drugs may also affect the quantity and quality of milk. Among drugs, corticosteroids are commonly used agents in
Animals.
Corticosteroids are a big group of naturally occurring and synthetic chemical
compounds used in veterinary as well as in human medicine. Corticosteroids
are immunosuppressive,
anti-inflammatory and also important for carbohydrate, lipid metabolism,
regulation of blood pressure and maintenance of muscle tone and bone density (Kufe et al. 2003).
Among corticosteroids,
Dexamethasone is
a synthetic corticosteroid and has pharmacological effects including anti-inflammatory,
anti-toxic, anti-allergic and anti-rheumatic activities. Therefore, it is
widely used in veterinary clinical treatment of maternal metabolic diseases to
treat infectious diseases and it is also one of the commonly used drugs in
livestock. However, DXM can also cause certain adverse reactions to animals,
such as gastrointestinal reactions, allergic reactions, liver dysfunction, skin
and mucosal symptoms. Therefore, DXM is strictly forbidden to be used as a
growth hormone in animal-derived food globally. Many countries and
organizations have established the maximum residue limits (MRLs) for DXM in
animal foods (Li et al. 2021). (DXM)
is commonly used as a therapeutic as well as in in
high doses to treat
chronic inflammatory and autoimmune diseases, some neurological disease and to prevent hypersensitivity
reactions associated with certain medications (Sousa 2005; Ito et al. 2006). It has been reported that the long-term use of low
concentrations of DXM may have adverse effects on public health (Becker 2011; Reig et al. 2016). DXM residues
has been reported in the various biological samples such as urine, feces, meat,
milk and liver in different animals (Chen et
al. 2011; Cherlet et al. 2014). Importantly, their therapeutic use has also been restricted because of its
concentration above the maximum residue limits (MRLs) in milk and edible
tissues. The MRLs of DXM in milk samples are 0.3 μg/kg.
Reportedly, DXM residues may also affect milk composition in various species (Macrina et al. 2014). Due to the frequent use of DXM in
various illnesses, it may produce residues in dairy and other products of
animal origin aimed for human consumption. Hence, it is necessary to develop
comprehensive control measures to monitor DXM residues in goat milk because
goat milk is commonly consumed by children. Considering the
limited information on DXM residues its effects on clinical and on the milk
composition, this study was
designed to assess the residual potential of DXM, its effects on clinical and on the milk composition in
local goat breeds.
Materials and Methods
Experimental
Protocol
Six lactating healthy goats of mix breeds were used in
present study. The goats were kept indoor at Livestock Experimental Station,
Sindh Agriculture University Tandojam. The animals were acclimatized for three
weeks. All animals were dewormed and vaccinated before start of the experiment.
All animals were identified by the use of an ear tag assigned a number from G1
to G6. Dexamethasone (DXM) (Dexafar, Farvet
Pharmaceutical company) was administered intramuscularly to evaluate its
residual profile and its effect on clinical and on goat milk composition.
Treatment procedure
Milk samples were collected before as a control and after drug
administration. DXM was administered at a therapeutic
dose of 0.5 mg/kg BW intramuscularly (I.M.) for 03 consecutive days once daily
to six healthy lactating dairy goats (based on high yield
lactating animals). Then, milk samples were
collected at 2, 8, 16, 32, 48, 72, 96, 120, 144 and 168 h post drug
administration. Milk samples
were collected in two set of test tubes, one set containing 5 mL for residual
analysis which was kept at -35°C until analysis and another set of test tube having 100 mL for milk composition which was analyzed immediately. The effect of
DXM on milk composition and its analysis was investigated at the Department of Animal Products
Technology, Sindh Agriculture University, Tandojam. For
residual analysis, milk samples were brought in ice bags to Veterinary Research
Institute Peshawar, Khyber Pakhtunkhwa.
Clinical
parameters
Vitals: Pulse rate (PR), Respiratory rate (RR) and
rectal temperature (RT) recorded before administration of DXM and after 2, 8,
16, 32, 48, 72, 96, 120, 144 and 168 h post dosage regimen respectively.
Analysis of milk
Fat content: For the determination of fat content, Gerber method was used as described by
Kleyn et al. (2001). Briefly, 11 mL milk sample was mixed with 10 mL of 90% sulfuric acid and 01 mL amyl
alcohol in Butyrometer and then closed
with a rubber cork. The Butyrometer was
placed in a Gerber machine and centrifuged for 05 min at 1100 rpm. The
percentage of fat was identified on the scale of butyrometer.
Protein content: Protein content determination
was carried according to Barbano et al. (1999). Briefly, a 05 mL milk sample was used in Micro-Kjeldahl digester in the existence of catalyst
0.2 g CuSO4 and 02 g Sodium/Potassium Sulphate where 30 mL H2SO4
was used. The digested sample was diluted by adding 250 mL distilled
water. Subsequently, 05 mL diluted sample
was taken and distilled with 40% of Sodium hydroxide using Micro-Kjeldahl distillation unit where steam was
distilled in 05 mL of 2% H3BO3 (Boric acid) containing an
indicator for 03 min. The Ammonia trapped in H3BO3 and
was determined by titrating with 0.1 N HCl. The Nitrogen Percentage was
analyzed using the formula written as under:
Where;
V1=Value of titrated milk sample
V2= Value of titrated blank
sample
Protein content was evaluated by
modifying nitrogen percentage to protein, believing that, all nitrogen was
available in milk as a protein ie, protein percentage = N% × conversion factor.
Conversion factor = 100/N% in milk products (i.e., 15.66).
Lactose content: Milk Lactose determination was done through difference method using the
following formula: Lactose% = TS% - (Fat% + Protein% + Ash%)
Solid not fat content
(SNF): Determination
of SNF content in milk was performed by difference method using following
formula: Solid Not Fat%= TS% - Fat%
Fig. 1: Mean values of Clinical Parameters of goats (n=6) obtained after I/M
administration of dexamethasone
Fig. 2: Residue analysis of intramuscularly
administered dexamethasone at the therapeutic dose of 0.5 mg/kg BW once daily
for 3 consecutive days in goat (n=6) milk
Residual detection:
The
residues of DXM in goat’s milk were determined using Direct Competitive ELISA
(AgraQuant® COKDA0800) according to manufacturer’s instructions.
Statistical analyses
Statistical analysis was
performed using a computer program,
Student Edition of Statistic (SXW), Version 8.1 (Copyright 2005, Analytical Software,
USA). Further, data were analyzed by linear models, where analysis of variance with three- way ANOVA was done in case of significant difference existed; the
means were additional computed applying least significant difference (LSD) test
at 5 and 1% probability level.
Results
This study was aimed to observe various effects
associated with the short-term
administration of dexamethasone (DXM) in goat species.
Clinical
parameters
Heartbeat,
respiratory rate, rectal temperature
Pulse rate was increased (P <
0.05) at various time-points from 8 – 96 h however, it was decreased (P < 0.05)
at 168 h as compared to control. The respiratory rate was increased (P ˂ 0.05) at 2 h and at 8, 16, 32, 48, 72 and 96 h (P < 0.01) post-DXM
administration. The maximum increase of respiratory rate was noticed at 16 h
after treatment. Afterward, the respiratory rate gradually returned to
control value at 168 h. The rectal
temperature was increased (P < 0.05)
at 02 h post-treatment, while, this increase was (P ˃ 0.05) in subsequent hour in comparison to control (Fig. 1).
Dexamethasone
residues in milk
Administration of DEX increased (P < 0.01) its residual level at 02, 08, 16, 32, 48, 72, 96, 120
and 144 h. However, statistical analysis showed (P ˃ 0.05) increased value at 168 h. The highest and lowest
mean values of DEX residues in goat milk were found at 32 and 168 h following
DEX administration respectively (Fig. 2).
Effect of
dexamethasone on the composition of milk
Milk
fat: DXM administration increased (P ˂ 0.05) milk fat content at 2, 8, 16, 96 and 120 h as
compared to control whereas, this
increased (P < 0.01) was perceived at 32, 48 and 72 h. The highest and lowest mean values
of milk fat were noticed at 48 and 144 h
post drug administration respectively. The milk fat values at 144 and 168 h
were found statistically (P ˃ 0.05) as compared to control (Fig. 3).
Milk
protein: DXM administration increased (P < 0.05) at 2 and 96 h, whereas, at 8, 16, 32, 48, 72 and 120 h
increased (P < 0.01) milk protein
level. The highest and lowest mean values of milk
protein level were detected at
48 and 144 h post drug administration respectively. At 144 and 168 h, the values showed a non-significant
difference with the control value (Fig. 3).
Milk
sugar (lactose): The therapeutic dose of DXM
showed the (P ˃ 0.05) - in milk
lactose level at all designated time points of observations as compared to control (Fig. 3).
SNF:
The administration of DXM increased (P < 0.05) at 16, 32, 48, 72 and 96 h,
however, at 120 h, this increase was (P <
0.01). Then, the values at 144 and 168 h gradually returned to
pre-treatment level and were found (P ˃ 0.05) as compared to control value. The highest and lowest
mean values of SNF were apparent at 120 and 168 h post drug administration
respectively (Fig. 3).
Milk
yield: DXM-induced effects
caused decreased (P ˃ 0.05) in milk yield 2–16 h (203.83 ± 9.27), as compared to pre-treatment observations,
thereafter, a significantly decreased (P <
0.05). However, milk yield returned to control value at 168 h (206.67 ± 9.60)
in lactating goats (Fig. 4).
Discussion
In current
study, DXM at therapeutic dose of 0.5 mg/kg BW once daily for 03 days was
administered intramuscularly to observe its residual, clinical and its effects
on milk composition in goats. It was noticed that clinical indicators i.e., pulse rate, respiration rate and
rectal temperature
(Fig. 1) were increased following the administration of DXM. The current study
showed agreement with previous studies where it was also described (Becker
2011) that corticosteroids exhibits its effects on CVS as a result of its
effect on plasma volume, and electrolyte balance ,
synthesis of adrenaline and angiotensin levels, all of which leading in
maintaining normal blood pressure and cardiac output. Corticosteroids have
effects on the heart muscle responses, permeability fluid and electrolyte
balance concerned with proper carbohydrate, lipid metabolism, regulation of blood
pressure, and bone density (Becker 2011).
The increase in pulse rate (cardiac output) as well as the blood pressure has
also been reported with DXM treatment. Increase in pulse rate and blood
pressure have been observed in infants (Fauser et
al. 1993; Washburn et al. 2003). The increase in respiratory
rate in this study is also in accordance with the previous findings reported by
Ohlsson et al. (1992) and Durand et al. (2002)) in humans and
animals. It was stated that glucocorticoids have a positive inotropic effect on
the cardiopulmonary system. It stimulates heart muscle contraction and
increases heart rate, this increase in heart rate and
cardiac output increases the volume of blood flow (Washburn et al. 2003). This increased blood flow with CO2
crosses blood brain and blood CSF barriers. CO2 combines with H2O
to form H2CO3 that dissociates into HCO3 Ions and H+
ions. This H+ stimulates chemo-sensitive area (Carotid bodies at the
bifurcation of common carotid arteries). It has been reported in fetal sheep
that the increased respiration and blood pressure in part is related to the
glucocorticoid-induced increased pulmonary angiotensin conversion enzyme (ACE) (Zimmermann et al. 2003). The increase
in rectal temperature in this study is supported by previous
findings of
Coelho et al. (1995) and Yared et al. (1998).
It was reported that DEX treatment, either before or after endotoxin injection
markedly inhibits temperature because of increased plasma interleukin and
prostaglandin. In contrast to this, the non-significant effects on present
study probably show the effect of DXM independent to temperature. It is
possible that the mild increase in temperature in this study is presumably due
to the inhibition or the release of many biologically active substances by DXM.
These results are also consistent with the results reported in the dog (Bughio et al. 2015) and in elephants (Mikota and Plumb 2013).
Fig. 3: Mean values of Milk analysis
of goats (n=6) obtained after administration of I/M dexamethasone once daily for
03 days
Fig. 4: Mean values milk yield of
goats (n=6) obtained after administration of I/M dexamethasone
Residual analysis
Following DXM administration once daily for three days,
noticed its residues in goat milk at 2, 8, 16, 32, 48, 72, 96, 120 and 144 h
(Fig. 2). The present results are supported by previous similar findings of Chen et al. (2011) and Cherlet et al. (2014). Draisci et al.
(2001) reported residues of DEX in biological samples i.e., urine, feces, meat, liver or milk
in various animals. Besides the clinical usage of DXM in relieving pain and inflammation, its use may result in drug
residues in dairy and other products of animal source aimed for human
consumption. The present findings are also comparable with previous studies in
which several other authors serious threats have been reported for long-term
usage of low concentrations of DXM, having adverse effects on public health (Becker 2011; Reig et al. 2016). Additionally, its therapeutic use has also been limited due to the launching of MRLs in milk and edible tissues. DXM is 50 times more powerful than the steroid cortisol (Becker 2011). It has been stated that Fairclough et al. (1981) I.M
administration of DXM most probably due to the formation of phosphate and
acetate esters which can lead to the sustained
release of DXM into the systemic circulation. Coelho
et al. (1995) also reported
that with the administration of phosphate and acetate esters plasma levels of
DEX is also elevated. So, accumulation in plasma or muscles as from
I.M. injections, one can surely expect residues in milk. DXM are administered
to animals either by injections (parenterally), orally in feed/water, topically
on the skin or by intramammary and intrauterine infusions and may lead to
residues of drugs in foods of animal origin such as milk, meat, and eggs (Turnipseed
et al. 2011). Calves fed milk and/or colostrum’s from cows receiving
drugs are also included in the cause list of residues (Guest and Paige 1991).
The result of the current study are
also consistent with those observed by Falahatpisheh et al. (2011), who
reported residues of DXM in cow milk via
ELISA. Somewhat similar observations were also noticed by (Caloni et
al. 2000;
Parmar et al. 2021) who found
residues of DEX in lactating cows after administration of a therapeutic dose of DXM once daily, they
further stated that recommended doses exceeded the maximum residue limit of DXM
and suggested a withdrawal period of 3–3.5
days in order to avoid its residues.
Effects of
DEX on goat milk composition
DXM administration at therapeutic dose i.e., 0.5 mg/kg BW once daily for three
days, caused a significant increase in Fat content at 48 h and non-significant
at 144 and 168 h post drug administration (Fig. 3). The fat slowly increased
and obtained peak level at 48 h then
gradually it returned to decrease at 168 h. It has been reported that due to
the lack of negative effect of DEX on fat’s fluid secretion increased the
concentration of fat in the treated cows (Varner
and Johnson 2003). DEX significantly increased protein level at 48 h in
goats and non-significant at 168 h after drug administration (Fig. 3). The
concentration of protein increased then decreased and remained directly
proportional to the changes in the milk yield. The secretion of protein was reduced
after 48 h. The decline of unwanted effect of DEX on protein on fluid secretion
clarifies the increase in the concentration of protein in the treated animals (Varner and Johnson 2003). The present finding
for milk protein content was found in contrast to those observed by Shamay et al. (2000). They reported
decreased level of protein in milk after induction of DXM in cows. This
contrast may be attributed to interspecies differences between cow and goat.
Similar findings were also reported by Varner
and Johnson (2003) also reported similar finding, he reported that there
is decreased level of protein content in
milk composition. These variant findings may be due to climatic or nutritional
factors which ultimately have caused increased protein level in current study.
The dose of 0.5 mg/kg BW of DEX showed a non-significant
decrease in lactose content post drug administration (Fig. 3). The present
findings of lactose content are in agreement with previous findings of Silanikove et
al. (2006). They reported decreased level of lactose content in milk
following DXM administration in cows. The
basic cause in this decreased level of
lactose in milk might be due to the relation between the activation of
hypothalamic pituitary adrenal axis and reduction in the output of osmotic
components from the alveoli into the gland lumen through the production of active biological substance from β-casein by the plasmin in the
milk. This decreased level of lactose
also may involve another factor such as decrease secretion of milk from glandular
cells which resulted in reversion of lactose level to pre-treatment values in a
directly proportional manner (Silanikove et
al. 2006).
The
therapeutic dose of 0.5 mg/kg BW of DEX initially exhibited non-significant
increase in SNF. Later, SNF significantly
increased from 16 to 120 h and then gradually returned to control level at 144
and 168 h post treatment (Fig. 3). The present result is in accordance with
previous findings in which it has been reported that DXM
Residues affected milk composition in various species (Shamay et al. 2000; Thanasak et al. 2004; Macrina et al.
2014). The current result of
milk SNF content showed agreement with previous
studies where it was also found increased
level of SNF content in milk following DXM administration in the cows (Walsh et al. 1981). The basic
cause in this increased level of SNF in
milk might be due to the genetic potential of individual animals, age, stage of
lactation, infections of udder and the type of feeding.
Milk Yield
In the present study milk yield non-significantly
decreased by therapeutic administration of DXM in lactating goats till 16 h.
Afterward, a significant decrease was observed in milk yield up to 144 h then returned to pretreatment level
at 168 h (Fig. 4). Similar observation in
agreement was also reported by Shamay et al.
(2000), who recorded decreased in milk yield with the administration of
a therapeutic dose of DXM in lactating
cows. It has been reported that administration of ACTH and DXM to lactating
cows caused a proportional decrease in milk yield (Hartmann and Kronfeld 2003). Reportedly, this decrease in milk
yield might be due to the disruption of the cellular
integrity of mammary epithelial cells of tight junctions which have caused lower milk yield in goats (Stelwagen et al. 2015). Another
possible factor in which milk yield decreased may be attributed due to increase in milk sodium and chlorine due to
their leakage from blood and decrease in potassium concentration which is leaked
from milk to blood due to the administration of DEX (Stelwagen et al. 2014). It has been reported that
dexamethasone treatment lowered mammary uptake of glucose, resulted in
decreasing milk yield (Shamay et al.
2000).
Conclusion
It
has been concluded from present study that the dexamethasone residues were
found in the milk of goat up to 32 h then gradually decreased up to 168 h. Milk
fat and protein increased at in 48 h then
decreased till 168 h. Milk lactose showed non-significant increase which
completely returned to pre-medication
level at 48 h. Whereas, SNF of milk was increased upto 120 h and decreased at 168 h. Pulse rate, respiratory rate and
rectal temperature increased during initial days later on, returned to control
level at 168 h post DEX administration in goat.
Acknowledgment
The
authors would like to thanks, the Department of Animal Products Technology,
Sindh Agriculture University, Tandojam and Veterinary Research Institute
Peshawar, Khyber Pakhtunkhwa for providing research facilities. Thank you to
all the staff of the laboratories, and guidance throughout the execution of the
experiments.
Author
Contributions
MTK carried out the experiments; SB and RB planned the
experiments, SS and GM analyzed the data, ZL conceived the experiment; MBA
wrote the manuscript.
Conflicts of
Interest
All authors declare no conflicts of interest.
Data
Availability
The data will
be made available on acceptable requests to the corresponding author.
Ethics
Approval
Not
applicable.
References
Barbano
DM, JL Clark, CE Dunham, RJ Flemin (1999). Kjeldahl method for determination of
total nitrogen content of milk: Collaborative study. J Assoc Off Anal Chem 73:849‒859
Becker
KL (2011). Principles and practice of
endocrinology and metabolism. Lippincott Williams & Wilkins
Bughio
S, T Qureshi, E Daraghmah, M Malhi, A Tunio (2015). Evaluation of clinical and
blood biochemical effects of dexamethasone in goat species. Pak J Agric Agric Eng Vet Sci 31:298‒307
Caloni
F, C Belloli, G Crescenzo, P Ormas, P Archimbault (2000). Determination of
dexamethasone in milk of dairy cows by immuno-enzymatic assay. Vet Hum Toxic 42:345‒348
Chen
D, Y Tao, Z Liu, H Zhang, Z Liu, Y Wang, L Huang, Y Pan, D Peng, M Dai, X Wang,
Z Yuan (2011). Development of a liquid chromatography-tandem mass spectrometry
with pressurized liquid extraction for determination of glucocorticoid residues
in edible tissues. J Chromatgr B 879:174‒180
Cherlet
M, SD Baere, PD Backer (2014). Quantitative determination of dexamethasone in
bovine milk by liquid chromatography–atmospheric pressure chemical
ionization–tandem mass spectrometry. J
Chromatgr B 805:57‒65
Coelho
MM, G Luheshi, SJ Hopkins, IR Pela, NJ Rothwell (1995). Multiple mechanisms
mediate antipyretic action of glucocorticoids. Amer J Physiol Regul Integr Compar Physiol 269:527‒535
Draisci
R, C Marchiafava, L Palleschi, P Cammarata, S Cavalli (2001). Accelerated
solvent extraction and liquid chromatography–tandem mass spectrometry quantitation
of corticosteroid residues in bovine liver. J
Chromatogr B Biomed Sci Appl 753:217‒223
Durand
M, ME Mendoza, P Tantivit, A Kugelman, C McEvoy (2002). A randomized trial of
moderately early low-dose dexamethasone therapy in very low birth weight
infants: Dynamic pulmonary mechanics, oxygenation and ventilation. Pediatrics 109:262‒268
Fairclough
RJ, JT Hunter, RAS Welch (1981). Dexamethasone concentrations in plasma and
milk of cows following the injection of long-and short-acting dexamethasone
esters. Aust J Biol Sci 34:313‒320
Falahatpisheh
H, MA Dabbagh, I Tayebi, M Mahmoudian, H Akbarein, S Rastgoo (2011). A
primordial survey of phenylbutazone, dexamethasone and estradiol residues in
pasteurized milks of tehran, iran as a potential risk for citizens
Fauser
A, F Pohlandt, P Bartmann, L Gortner (1993). Rapid increase of blood pressure
in extremely low birth weight infants after a single dose of dexamethasone. Eur J Pediatr 152:354‒356
Guest
GB, JC Paige (1991). The magnitude of the tissue residue problem with regard to
consumer needs. J Amer Vet Med Assoc 5:805‒808
Hartmann
P, D Kronfeld (2003). Mammary blood flow and glucose uptake in lactating cows
given dexamethasone. J Dairy Sci 56:896‒902
Ito
K, KF Chung, IM Adcock (2006). Update on glucocorticoid action and resistance. J Aller Clin Immunol 117:522‒543
Kleyn
DH, JM Lynch, DM Barbano, MJ Bloom, MW Mitchell (2001). Determination of fat in
raw and processed milks by the Gerber method: collaborative study. J AOAC Intl 84:1499‒1508
Kufe
DW, RE Pollock, RR Weichselbaum, JCB Jr, TS Gansier, JF Holland (2003). Cancer medicine. American Cancer Society
Inc. and BC Decker. Inc., Hamiton, Ontario
Li X, X Chen,
J Wu, Z Liu, J Wang, C Song, S Zhao, H Lei, Y Sun (2021). Portable, rapid, and
sensitive time-resolved fluorescence immunochromatography for on-site detection
of dexamethasone in milk and pork. Foods 10:1339
Macrina
AL, ACW Kauf, DA Pape-Zambito, RS Kensinger (2014). Induced lactation in
heifers: Effects of dexamethasone and age at induction on milk yield and
composition. J Dairy Sci 97:1446‒1453
Mikota
SK, DC Plumb (2013). Doramectin.
In: Elephant Care Int. Junio: https://www.facebook.com/ElephantCareInternational/
(Accessed: 22 January 2022)
Ohlsson
A, SA Calvert, M Hosking, AT Shennan (1992). Randomized controlled trial of
dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent
chronic lung disease. Acta Paediatr 81:751‒756
Parmar JK, KK
Chaubey, V Gupta, MN Bharath (2021). Assessment of various veterinary drug
residues in animal originated food products. Vet World 14:1650–1664
Reig
M, L Mora, JL Navarro, F Toldra (2016). A chromatography method for the
screening and confirmatory detection of dexamethasone. Meat Sci 74:676‒680
Roadhouse
CL, JL Henderson (1950). The Market-milk Industry.
2nd Edn. Magraw Hill Brok Company, New York, USA
Shamay
A, F Shapiro, H Barash, I Bruckental, N Silanikove (2000). Effect of
dexamethasone on milk yield and composition in dairy cows. Ann Zootech
49:343-352
Silanikove
N, A Shamay, D Shinder, A Moran (2006). Stress down regulates milk yield in
cows by plasmin induced β-casein
product that blocks K+ channels on the apical membranes. Life Sci 67:2201‒2212
Sousa
C (2005). The use of corticosteroids in veterinary dermatology. J Dermatol 85:10‒12
Stelwagen
K, VC Farr, SR Davis, CG Prosser (2015). EGTA-induced disruption of epithelial
cell tight junctions in the lactating caprine mammary gland. Amer J Physiol-Regul Integr Compar Physiol 269:848‒855
Stelwagen
K, S Davis, V Farr, C Prosser, R Sherlock (2014). Mammary epithelial cell tight
junction integrity and mammary blood flow during an extended milking interval
in goats. J Dairy Sci 77:426‒432
Thanasak
J, R Jorritsma, A Hoek, JP Noordhuizen, VP Rutten, KE Muller (2004). The
effects of a single injection of dexamethasone-21-isonicotinate on the
lymphocyte functions of dairy cows at two weeks post partum. Vet Res 35:103‒112
Turnipseed
SB, JM Storey, SB Clark, KE Miller (2011). Analysis of veterinary drugs and
metabolites in milk using quadrupole time-of-flight liquid
chromatography− mass spectrometry. J
Agric Food Chem 59:7569‒7581
Varner
M, B Johnson (2003). Influence of adrenocorticotropin upon milk production,
milk constituents, and endocrine measures of dairy cows. J Dairy Sci 66:458‒465
Walsh
JP, J Connolly, MG Fleming, M Keane, TCA McGann, GJ Ferrall (1981). Chemical Composition of Milk in Ireland.
Washburn
BE, JJ Millspaugh, JH Schulz, SB Jones, T Mong (2003). Using fecal
glucocorticoids for stress assessment in mourning doves. Condor 105:696‒706
Yared
JP, NJ Starr, L Hoffman-Hogg, CA Bashour, SR Insler, M Connor, M Piedmonte, DM
Cosgrove (1998). Dexamethasone decreases the incidence of shivering after
cardiac surgery: a randomized, double-blind, placebo-controlled study. Anesth Analg 87:795‒799
Zimmermann H, DS Gardner, JK Jellyman, AL
Fowden, DA Giussani, AJ Forhead (2003). Effect of dexamethasone on pulmonary
and renal angiotensin-converting enzyme concentration in fetal sheep during
late gestation. Amer J Obst Gynecol 189:1467‒1471